Case File
efta-01938530DOJ Data Set 10OtherEFTA01938530
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01938530
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Mortimer Zuckerma
From:
Jeffrey Epstein
Sent
Mon 1/13/2014 2:26:52 PM
Subject Fwd: M
there is no plan, the facts have yet to be gathered and analyzed. . the IRS pre ruling was
negative re cancellation of indebtedbess because the questions were the wrong ones.. this is silly,
Forwarded m
From: Ellen Harrison."
Date: Mon, Jan 13, 2014 at 10:23 AM
Subject: Re: M
To: Jeffrey Epstein <[email protected]>
We are getting way ahead of the situation. We don't know if there will be any debt. Interest can
accrue, of course.
Sent from my iPhone
On Jan 13, 2014, at 9:20 AM, Jeffrey Epstein leevacationOgmail.com> wrote:
how would you service the debt of Rr
On Mon, Jan 13, 2014 at 9:25 AM, Ellen Harrison a
wrote:
On your question about Mort's basis in the notes, I checked with Brian and He
said the notes had not been written down so I gave you bad information. Sorry.
In my opinion, your purchase of the receivables from Mort would not cure the COD issue
we are worried about. Even if the sale generated a capital loss, that would not
offset ordinary income from COD. However, we will continue to explore this
along with other ideas
My partner is working on an accounting for the 1983 and 1996 trusts. She is still getting
data. This has been in process for less than a month. I expect that it will be some
time before it is done because I am told that the records prior to 2000 are limited.
SRR is appraising R&R. We are hoping, of course, that the cash flow will be sufficient to
cover the preference. Since we don't have the appraisal or the preference yet we
don't know whether this will be a problem. If it is, l would use debt to reduce
value so cash flow would cover the preference. This is a problem under section
2701, because the common has to equal 10% of enterprise value before debt, but
we will figure it out.
Sent from my iPhone
EFTA_R1_00395537
EFTA01938530
On Jan 13, 2014, at 7:19 AM, Jeffrey Epstein <jeevacation@gmaitcom> wrote:
EH you told me that morts basis in the 12 percent notes had been
written down, can you explain, . can you tell me the status of the
trust accounting to date. ? you stated that Rand It was being
valued, and planned to put it in a preferred partnership. ? what is the
plan if the cashflow is not enough to pay the preferred. ?
On Sun, Jan 12, 2014 at 2:30 PM, Ellen Harrison <
wrote:
> Hello
> I just left you a voicemail. I would like to speak with you briefly about the terms
of the deal you proposed to MZ so that we can ye it appropriate
analysis. Could you please give me a call at
r reply
to this email as soon as possible? We are trying to sc
u c a
conference call with tax advisors on Monday between 10 and 12 and
it would be very helpful to have your proposal in hand by then.
> Thanks and Happy New Year.
> Sent from my iPhone
***********************************************************
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation@gmail,com, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
***********************************************************
The information contained in this communication is
confidential, may be attorney-client privileged, may
EFTA_R1_00395538
EFTA01938531
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
*************
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_00395539
EFTA01938532
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
leevacationogmail.comEmail
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.